Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
Launched by THE UNIVERSITY OF HONG KONG · May 1, 2020
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 16 - 60 years old at the time of enrolment
- • Able to read and communicate in English and/or Chinese
- • Able to give informed consent
- • Using cannabis or marijuana as the primary psychoactive substance of abuse
- • Repeated and Active cannabis users as defined by Structured Clinical Interview for DSM-5 Disorders
- Exclusion Criteria:
- • Age \<16 years old
- • Unable to read English or Chinese
- • Unable to give informed consent
- • Had been diagnosed with other Substance Related Disorders, except for Tobacco Use Disorders due to the known frequent comorbid use for cannabis users (12)
- • Currently taking regular prescribed psychiatric medications, including antipsychotics, antidepressants, mood stabilizers, anti-epileptics, benzodiazepines, hypnotics, and anti-cholinergic medications.
- • Had been diagnosed with DSM-5 disorders, other than Cannabis Use and related disorders
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials